<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29238324</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Immunopathogenesis and Virus-Host Interactions of Enterovirus 71 in Patients with Hand, Foot and Mouth Disease.</ArticleTitle><Pagination><StartPage>2249</StartPage><MedlinePgn>2249</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2249</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2017.02249</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is a global infectious disease that affects millions of people. The virus is the main etiological agent for hand, foot, and mouth disease with outbreaks and epidemics being reported globally. Infection can cause severe neurological, cardiac, and respiratory problems in children under the age of 5. Despite on-going efforts, little is known about the pathogenesis of EV71, how the host immune system responds to the virus and the molecular mechanisms behind these responses. Moreover, current animal models remain limited, because they do not recapitulate similar disease patterns and symptoms observed in humans. In this review the role of the host-viral interactions of EV71 are discussed together with the various models available to examine: how EV71 utilizes its proteins to cleave host factors and proteins, aiding virus replication; how EV71 uses its own viral proteins to disrupt host immune responses and aid in its immune evasion. These discoveries along with others, such as the EV71 crystal structure, have provided possible targets for treatment and drug interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cox</LastName><ForeName>Jonathan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiscox</LastName><ForeName>Julian A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solomon</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ooi</LastName><ForeName>Mong-How</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Institute of Health and Community Medicine, Universiti Malaysia Sarawak, Samarahan, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics, Sarawak General Hospital, Kuching, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Lisa F P</ForeName><Initials>LFP</Initials><AffiliationInfo><Affiliation>Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>IS-HPU-1112-10117</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_15096</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G116/194</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RP-PG-0108-10048</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>EME/12/205/28</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">and mouth disease</Keyword><Keyword MajorTopicYN="N">foot</Keyword><Keyword MajorTopicYN="N">hand</Keyword><Keyword MajorTopicYN="N">host interactions</Keyword><Keyword MajorTopicYN="N">immune response</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>11</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29238324</ArticleId><ArticleId IdType="pmc">PMC5713468</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2017.02249</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>AbuBakar S., Chee H.-Y., Al-Kobaisi M. F., Xiaoshan J., Bing Chua K., Kit Lam S. (1999). Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res. 61 1&#x2013;9. 10.1016/S0168-1702(99)00019-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1702(99)00019-2</ArticleId><ArticleId IdType="pubmed">10426204</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreoni A. R., Colton A. S. (2017). Coxsackievirus B5 associated with hand-foot-mouth disease in a healthy adult. JAAD Case Rep. 3 165&#x2013;168. 10.1016/j.jdcr.2017.01.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdcr.2017.01.026</ArticleId><ArticleId IdType="pmc">PMC5376252</ArticleId><ArticleId IdType="pubmed">28413820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang L. W., Koh B. K., Chan K. P., Chua L. T., James L., Goh K. T. (2009). Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann. Acad. Med. Singapore 38 106&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">19271036</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M., Ami Y., Wakita T., Shimizu H. (2008). Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J. Virol. 82 1787&#x2013;1797. 10.1128/JVI.01798-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01798-07</ArticleId><ArticleId IdType="pmc">PMC2258712</ArticleId><ArticleId IdType="pubmed">18057246</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M., Nagata N., Iwata N., Ami Y., Suzaki Y., Mizuta K., et al. (2007). An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J. Virol. 81 9386&#x2013;9395. 10.1128/jvi.02856-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02856-06</ArticleId><ArticleId IdType="pmc">PMC1951441</ArticleId><ArticleId IdType="pubmed">17567701</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendig J. W., Fleming D. M. (1996). Epidemiological, virological, and clinical features of an epidemic of hand, foot, and mouth disease in England and Wales. Commun. Dis. Rep. CDR Rev. 6 R81&#x2013;R86.</Citation><ArticleIdList><ArticleId IdType="pubmed">8664928</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessaud M., Razafindratsimandresy R., Nougairede A., Joffret M. L., Deshpande J. M., Dubot-Peres A., et al. (2014). Molecular comparison and evolutionary analyses of VP1 nucleotide sequences of new African human enterovirus 71 isolates reveal a wide genetic diversity. PLOS ONE 9:e90624. 10.1371/journal.pone.0090624</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0090624</ArticleId><ArticleId IdType="pmc">PMC3944068</ArticleId><ArticleId IdType="pubmed">24598878</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracho M. A., Gonz&#xe1;lez-Candelas F., Valero A., C&#xf3;rdoba J., Salazar A. (2011). Enterovirus Co-infections and onychomadesis after hand, foot, and mouth disease, Spain, 2008. Emerg. Infect. Dis. 17 2223&#x2013;2231. 10.3201/eid1712.110395</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1712.110395</ArticleId><ArticleId IdType="pmc">PMC3311182</ArticleId><ArticleId IdType="pubmed">22172227</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B. A., Pallansch M. A. (1995). Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 39 195&#x2013;205. 10.1016/0168-1702(95)00087-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00087-9</ArticleId><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro C. M., Cruz A. C., Silva E. E., Gomes Mde L. (2005). Molecular and seroepidemiologic studies of Enterovirus 71 infection in the State of Para, Brazil. Rev. Inst. Med. Trop. Sao Paulo 47 65&#x2013;71. 10.1590/S0036-46652005000200002</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0036-46652005000200002</ArticleId><ArticleId IdType="pubmed">15880216</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L. G., Parashar U. D., Lye M. S., Ong F. G., Zaki S. R., Alexander J. P., et al. (2000). Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin. Infect. Dis. 31 678&#x2013;683. 10.1086/314032</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314032</ArticleId><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C. S., Lin Y. T., Shih S. R., Lee C. C., Lee Y. C., Tai C. L., et al. (2005). Design, synthesis, and antipicornavirus activity of 1-[5-(4-arylphenoxy)alkyl]-3-pyridin-4-ylimidazolidin-2-one derivatives. J. Med. Chem. 48 3522&#x2013;3535. 10.1021/jm050033v</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm050033v</ArticleId><ArticleId IdType="pubmed">15887961</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C. Y., Li J. R., Ou Y. C., Chen W. Y., Liao S. L., Raung S. L., et al. (2015). Enterovirus 71 infection caused neuronal cell death and a cytokine expression in cultured rat neural cells. IUBMB Life 67 789&#x2013;800. 10.1002/iub.1434</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1434</ArticleId><ArticleId IdType="pubmed">26399559</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.-Y., Lin T.-Y., Hsu K.-H., Huang Y.-C., Lin K.-L., Hsueh C., et al. (1999a). Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354 1682&#x2013;1686. 10.1016/S0140-6736(99)04434-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(99)04434-7</ArticleId><ArticleId IdType="pubmed">10568570</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L. Y., Lin T. Y., Huang Y. C., Tsao K. C., Shih S. R., Kuo M. L., et al. (1999b). Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr. Infect. Dis. J. 18 1092&#x2013;1096. 10.1097/00006454-199912000-00013</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-199912000-00013</ArticleId><ArticleId IdType="pubmed">10608631</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S. C., Lin J. Y., Lo L. Y., Li M. L., Shih S. R. (2004). Diverse apoptotic pathways in enterovirus 71-infected cells. J. Neurovirol. 10 338&#x2013;349. 10.1080/13550280490521032</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280490521032</ArticleId><ArticleId IdType="pubmed">15765805</ArticleId></ArticleIdList></Reference><Reference><Citation>Chea S., Cheng Y. B., Chokephaibulkit K., Chotpitayasunondh T., van Doorn H. R., Hafy Z., et al. (2015). Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia. Emerg. Infect. Dis. 21:e140992. 10.3201/eid2101.140992</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2101.140992</ArticleId><ArticleId IdType="pmc">PMC4285270</ArticleId><ArticleId IdType="pubmed">25531166</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.-S., Yao Y.-C., Lin S.-C., Lee Y.-P., Wang Y.-F., Wang J.-R., et al. (2007). Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J. Virol. 81 8996&#x2013;9003. 10.1128/JVI.00236-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00236-07</ArticleId><ArticleId IdType="pmc">PMC1951457</ArticleId><ArticleId IdType="pubmed">17567704</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L.-C., Yeh T.-M. (2009). Enterovirus 71 infection of human immune cells induces the production of proinflammatory cytokines. J. Biomed. Lab. Sci. 21 82&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L.-L., Kung Y.-A., Weng K.-F., Lin J.-Y., Horng J.-T., Shih S.-R. (2013). Enterovirus 71 infection cleaves a negative regulator for viral internal ribosomal entry site-driven translation. J. Virol. 87 3828&#x2013;3838. 10.1128/jvi.02278-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02278-12</ArticleId><ArticleId IdType="pmc">PMC3624201</ArticleId><ArticleId IdType="pubmed">23345520</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T.-C., Chang H.-Y., Lin P.-F., Chern J.-H., Hsu J. T.-A., Chang C.-Y., et al. (2009). Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71. Antimicrob. Agents Chemother. 53 2740&#x2013;2747. 10.1128/AAC.00101-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00101-09</ArticleId><ArticleId IdType="pmc">PMC2704669</ArticleId><ArticleId IdType="pubmed">19414569</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T. C., Liu S. C., Huang P. N., Chang H. Y., Chern J. H., Shih S. R. (2008). Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants. J. Biomed. Sci. 15 291&#x2013;300. 10.1007/s11373-007-9228-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11373-007-9228-5</ArticleId><ArticleId IdType="pubmed">18196474</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y. C., Yu C. K., Wang Y. F., Liu C. C., Su I. J., Lei H. Y. (2004). A murine oral enterovirus 71 infection model with central nervous system involvement. J. Gen. Virol. 85(Pt 1) 69&#x2013;77. 10.1099/vir.0.19423-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.19423-0</ArticleId><ArticleId IdType="pubmed">14718621</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H. Y., Huang Y. C., Yen T. Y., Hsia S. H., Hsieh Y. C., Li C. C., et al. (2014). The correlation between the presence of viremia and clinical severity in patients with enterovirus 71 infection: a multi-center cohort study. BMC Infect. Dis. 14:417. 10.1186/1471-2334-14-417</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-417</ArticleId><ArticleId IdType="pmc">PMC4133623</ArticleId><ArticleId IdType="pubmed">25069383</ArticleId></ArticleIdList></Reference><Reference><Citation>Chern J. H., Shia K. S., Hsu T. A., Tai C. L., Lee C. C., Lee Y. C., et al. (2004). Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors. Bioorg. Med. Chem. Lett. 14 2519&#x2013;2525. 10.1016/j.bmcl.2004.02.092</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2004.02.092</ArticleId><ArticleId IdType="pubmed">15109643</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua B. H., Phuektes P., Sanders S. A., Nicholls P. K., McMinn P. C. (2008). The molecular basis of mouse adaptation by human enterovirus 71. J. Gen. Virol. 89(Pt 7) 1622&#x2013;1632. 10.1099/vir.0.83676-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83676-0</ArticleId><ArticleId IdType="pubmed">18559932</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov M., Voroshilova M., Shindarov L., Lavrova I., Gracheva L., Koroleva G., et al. (1979). Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch. Virol. 60 329&#x2013;340. 10.1007/BF01317504</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01317504</ArticleId><ArticleId IdType="pubmed">228639</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung P. W., Huang Y. C., Chang L. Y., Lin T. Y., Ning H. C. (2001). Duration of enterovirus shedding in stool. J. Microbiol. Immunol. Infect. 34 167&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">11605806</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung Y. C., Ho M. S., Wu J. C., Chen W. J., Huang J. H., Chou S. T., et al. (2008). Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 26 1855&#x2013;1862. 10.1016/j.vaccine.2008.01.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2008.01.058</ArticleId><ArticleId IdType="pubmed">18329759</ArticleId></ArticleIdList></Reference><Reference><Citation>Crabol Y., Pean P., Mey C., Duong V., Richner B., Laurent D., et al. (2017). A prospective, comparative study of severe neurological and uncomplicated hand, foot and mouth forms of paediatric enterovirus 71 infections. Int. J. Infect. Dis. 59 69&#x2013;76. 10.1016/j.ijid.2017.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2017.04.005</ArticleId><ArticleId IdType="pubmed">28438677</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake J. W., Holland J. J. (1999). Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. U.S.A. 96 13910&#x2013;13913. 10.1073/pnas.96.24.13910</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.24.13910</ArticleId><ArticleId IdType="pmc">PMC24164</ArticleId><ArticleId IdType="pubmed">10570172</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q., Langereis M. A., Lork M., Nguyen M., Hato S. V., Lanke K., et al. (2014). Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J. Virol. 88 3369&#x2013;3378. 10.1128/jvi.02712-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenton C., Scott L. J., Plosker G. L. (2004). Palivizumab: a review of its use as prophylaxis for serious respiratory syncytial virus infection. Paediatr. Drugs 6 177&#x2013;197. 10.2165/00148581-200406030-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00148581-200406030-00004</ArticleId><ArticleId IdType="pubmed">15170364</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferson M. J., Bell S. M. (1991). Outbreak of Coxsackievirus A16 hand, foot, and mouth disease in a child day-care center. Am. J. Public Health 81 1675&#x2013;1676. 10.2105/AJPH.81.12.1675</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.81.12.1675</ArticleId><ArticleId IdType="pmc">PMC1405294</ArticleId><ArticleId IdType="pubmed">1746672</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald K. A., McWhirter S. M., Faia K. L., Rowe D. C., Latz E., Golenbock D. T., et al. (2003). IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4 491&#x2013;496. 10.1038/ni921</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni921</ArticleId><ArticleId IdType="pubmed">12692549</ArticleId></ArticleIdList></Reference><Reference><Citation>Flett K., Youngster I., Huang J., McAdam A., Sandora T. J., Rennick M., et al. (2012). Hand, foot, and mouth disease caused by Coxsackievirus A6. Emerg. Infect. Dis. 18 1702&#x2013;1704. 10.3201/eid1810.120813</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1810.120813</ArticleId><ArticleId IdType="pmc">PMC3471644</ArticleId><ArticleId IdType="pubmed">23017893</ArticleId></ArticleIdList></Reference><Reference><Citation>Flewett T. H., Warin R. P., Clarke S. K. R. (1963). &#x2018;Hand, foot, and mouth disease&#x2019; associated with Coxsackie A5 virus. J. Clin. Pathol. 16 53&#x2013;55. 10.1136/jcp.16.1.53</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.16.1.53</ArticleId><ArticleId IdType="pmc">PMC480485</ArticleId><ArticleId IdType="pubmed">13945538</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo D. G., Alonso S., Phoon M. C., Ramachandran N. P., Chow V. T., Poh C. L. (2007). Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res. 125 61&#x2013;68. 10.1016/j.virusres.2006.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2006.12.005</ArticleId><ArticleId IdType="pubmed">17222936</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K., Nagata N., Sato Y., Ong K. C., Wong K. T., Yamayoshi S., et al. (2013). Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc. Natl. Acad. Sci. U.S.A. 110 14753&#x2013;14758. 10.1073/pnas.1217563110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217563110</ArticleId><ArticleId IdType="pmc">PMC3767555</ArticleId><ArticleId IdType="pubmed">23959904</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto T., Chikahira M., Yoshida S., Ebira H., Hasegawa A., Totsuka A., et al. (2002). Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol. Immunol. 46 621&#x2013;627. 10.1111/j.1348-0421.2002.tb02743.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.2002.tb02743.x</ArticleId><ArticleId IdType="pubmed">12437029</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukata M., Vamadevan A. S., Abreu M. T. (2009). Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. Semin. Immunol. 21 242&#x2013;253. 10.1016/j.smim.2009.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2009.06.005</ArticleId><ArticleId IdType="pubmed">19748439</ArticleId></ArticleIdList></Reference><Reference><Citation>Gantt S., Yao L., Kollmann T. R., Casper C., Zhang J., Self S. G. (2013). Implications of age-dependent immune responses to enterovirus 71 infection for disease pathogenesis and vaccine design. J. Pediatric Infect. Dis. Soc. 2 162&#x2013;170. 10.1093/jpids/pit017</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/pit017</ArticleId><ArticleId IdType="pubmed">26619463</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths M. J., Ooi M. H., Wong S. C., Mohan A., Podin Y., Perera D., et al. (2012). In enterovirus 71 encephalitis with cardio-respiratory compromise, elevated interleukin 1beta, interleukin 1 receptor antagonist, and granulocyte colony-stimulating factor levels are markers of poor prognosis. J. Infect. Dis. 206 881&#x2013;892. 10.1093/infdis/jis446</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jis446</ArticleId><ArticleId IdType="pubmed">22829643</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiwara A., Tagaya I., Yoneyama T. (1978). Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection. Intervirology 9 60&#x2013;63. 10.1159/000148922</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000148922</ArticleId><ArticleId IdType="pubmed">202573</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson L. A. (1998). Breastfeeding provides passive and likely long-lasting active immunity. Ann. Allergy Asthma Immunol. 81 523&#x2013;537. 10.1016/S1081-1206(10)62704-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1081-1206(10)62704-4</ArticleId><ArticleId IdType="pubmed">9892025</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y., Ong K. C., Gao Z., Zhao X., Anderson V. M., McNutt M. A., et al. (2014). Tonsillar crypt epithelium is an important extra-central nervous system site for viral replication in EV71 encephalomyelitis. Am. J. Pathol. 184 714&#x2013;720. 10.1016/j.ajpath.2013.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2013.11.009</ArticleId><ArticleId IdType="pubmed">24378407</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirata T., Merrill-Skoloff G., Aab M., Yang J., Furie B. C., Furie B. (2000). P-selectin glycoprotein ligand 1 (Psgl-1) is a physiological ligand for E-selectin in mediating T helper 1 lymphocyte migration. J. Exp. Med. 192 1669&#x2013;1676. 10.1084/jem.192.11.1669</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.192.11.1669</ArticleId><ArticleId IdType="pmc">PMC2193099</ArticleId><ArticleId IdType="pubmed">11104809</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M., Chen E. R., Hsu K. H., Twu S. J., Chen K. T., Tsai S. F., et al. (1999). An epidemic of enterovirus 71 infection in Taiwan. Taiwan enterovirus epidemic working group. N. Engl. J. Med. 341 929&#x2013;935. 10.1056/NEJM199909233411301</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogarth P. J. (ed.) (1982). &#x201c;Passive transfer of immunity,&#x201d; in Immunological Aspects of Mammalian Reproduction (Dordrecht: Springer; ) 150&#x2013;158. 10.1007/978-94-011-6859-5_7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-94-011-6859-5_7</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y. F., Yang F., Du J., Dong J., Zhang T., Wu Z. Q., et al. (2011). Complete genome analysis of Coxsackievirus A2, A4, A5, and A10 strains isolated from hand, foot, and mouth disease patients in China revealing frequent recombination of human enterovirus a. J. Clin. Microbiol. 49 2426&#x2013;2434. 10.1128/JCM.00007-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00007-11</ArticleId><ArticleId IdType="pmc">PMC3147834</ArticleId><ArticleId IdType="pubmed">21543560</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H.-I., Shih S.-R. (2015). Neurotropic enterovirus infections in the central nervous system. Viruses 7 6051&#x2013;6066. 10.3390/v7112920</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7112920</ArticleId><ArticleId IdType="pmc">PMC4664993</ArticleId><ArticleId IdType="pubmed">26610549</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang M.-L., Chiang P.-S., Chia M.-Y., Luo S.-T., Chang L.-Y., Lin T.-Y., et al. (2013). Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development. PLOS Negl. Trop. Dis. 7:e2067. 10.1371/journal.pntd.0002067</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002067</ArticleId><ArticleId IdType="pmc">PMC3573098</ArticleId><ArticleId IdType="pubmed">23459633</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang P.-N., Lin J.-Y., Locker N., Kung Y.-A., Hung C.-T., Lin J.-Y., et al. (2011). Far upstream element binding protein 1 binds the internal ribosomal entry site of enterovirus 71 and enhances viral translation and viral growth. Nucleic Acids Res. 39 9633&#x2013;9648. 10.1093/nar/gkr682</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr682</ArticleId><ArticleId IdType="pmc">PMC3239202</ArticleId><ArticleId IdType="pubmed">21880596</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.-W., Wang Y.-F., Yu C.-K., Su I.-J., Wang J.-R. (2012). Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology 422 132&#x2013;143. 10.1016/j.virol.2011.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.10.015</ArticleId><ArticleId IdType="pubmed">22078110</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes R. O., Roberts C. (1972). Hand, foot, and mouth disease associated with Coxsackie A9 virus. Lancet 2 751&#x2013;752. 10.1016/S0140-6736(72)92038-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(72)92038-7</ArticleId><ArticleId IdType="pubmed">4116159</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung H. C., Wang H. C., Shih S. R., Teng I. F., Tseng C. P., Hsu J. T. (2011). Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J. Infect. Dis. 203 1784&#x2013;1790. 10.1093/infdis/jir174</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir174</ArticleId><ArticleId IdType="pubmed">21536800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishimaru Y., Nakano S., Yamaoka K., Takami S. (1980). Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch. Dis. Child. 55 583&#x2013;588. 10.1136/adc.55.8.583</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.55.8.583</ArticleId><ArticleId IdType="pmc">PMC1627055</ArticleId><ArticleId IdType="pubmed">6254449</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao S. J., Yang F. L., Hsu Y. H., Chen H. I. (2004). Mechanism of fulminant pulmonary edema caused by enterovirus 71. Clin. Infect. Dis. 38 1784&#x2013;1788. 10.1086/421021</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/421021</ArticleId><ArticleId IdType="pmc">PMC7107954</ArticleId><ArticleId IdType="pubmed">15227628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kar B. R., Dwibedi B., Kar S. K. (2013). An outbreak of hand, foot and mouth disease in Bhubaneswar, Odisha. Indian Pediatr. 50 139&#x2013;142. 10.1007/s13312-013-0033-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13312-013-0033-0</ArticleId><ArticleId IdType="pubmed">22728634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataoka C., Suzuki T., Kotani O., Iwata-Yoshikawa N., Nagata N., Ami Y., et al. (2015). The role of VP1 amino acid residue 145 of enterovirus 71 in viral fitness and pathogenesis in a cynomolgus monkey model. PLOS Pathog. 11:e1005033. 10.1371/journal.ppat.1005033</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005033</ArticleId><ArticleId IdType="pmc">PMC4504482</ArticleId><ArticleId IdType="pubmed">26181772</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong W. X., Yan B., Yeo H., Tan E. L., Lee J. J., Ng J. K. W., et al. (2012). A non-mouse-adapted Enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J. Virol. 86 2121&#x2013;2131. 10.1128/JVI.06103-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06103-11</ArticleId><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiener T. K., Jia Q., Meng T., Chow V. T. K., Kwang J. (2014). A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved &#x201c;Knob&#x201d; region of VP3 protein. PLOS Negl. Trop. Dis. 8:e2895. 10.1371/journal.pntd.0002895</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002895</ArticleId><ArticleId IdType="pmc">PMC4038473</ArticleId><ArticleId IdType="pubmed">24875055</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K. H. (2010). Enterovirus 71 infection: an experience in Korea, 2009. Korean J. Pediatr. 53 616&#x2013;622. 10.3345/kjp.2010.53.5.616</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/kjp.2010.53.5.616</ArticleId><ArticleId IdType="pmc">PMC2994121</ArticleId><ArticleId IdType="pubmed">21189926</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu H., Shimizu Y., Takeuchi Y., Ishiko H., Takada H. (1999). Outbreak of severe neurologic involvement associated with Enterovirus 71 infection. Pediatr. Neurol. 20 17&#x2013;23. 10.1016/S0887-8994(98)00087-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0887-8994(98)00087-3</ArticleId><ArticleId IdType="pubmed">10029254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontsek P. (1994). Human type I interferons: structure and function. Acta Virol. 38 345&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">7793359</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z., Shi J., Liu Q., Huang Z. (2012). Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71. J. Virol. Methods 186 193&#x2013;197. 10.1016/j.jviromet.2012.06.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2012.06.025</ArticleId><ArticleId IdType="pubmed">22771741</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.-S., Chiang P.-S., Luo S.-T., Huang M.-L., Liou G.-Y., Tsao K.-C., et al. (2012). Incidence rates of enterovirus 71 infections in young children during a nationwide epidemic in Taiwan, 2008&#x2013;09. PLOS Negl. Trop. Dis. 6:e1476. 10.1371/journal.pntd.0001476</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001476</ArticleId><ArticleId IdType="pmc">PMC3279337</ArticleId><ArticleId IdType="pubmed">22348156</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y. P., Wang Y. F., Wang J. R., Huang S. W., Yu C. K. (2012). Enterovirus 71 blocks selectively type I interferon production through the 3C viral protein in mice. J. Med. Virol. 84 1779&#x2013;1789. 10.1002/jmv.23377</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23377</ArticleId><ArticleId IdType="pubmed">22997081</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Liu X., Ma Y., Sun Z., Yang Y., Jin Q., et al. (2010). The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 84 8051&#x2013;8061. 10.1128/jvi.02491-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02491-09</ArticleId><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Sun Z., Liu X., Jin Q., He B., Wang J. (2011). Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 85 8811&#x2013;8818. 10.1128/jvi.00447-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00447-11</ArticleId><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Xiao X., Xue Q., Jin Q., He B., Wang J. (2013). Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J. Virol. 87 1690&#x2013;1698. 10.1128/jvi.01855-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01855-12</ArticleId><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Liu L., Mo Z., Wang X., Xia J., Liang Z., et al. (2014). An inactivated enterovirus 71 vaccine in healthy children. N. Engl. J. Med. 370 829&#x2013;837. 10.1056/NEJMoa1303224</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.-P., Liang Z.-L., Gao Q., Huang L.-R., Mao Q.-Y., Wen S.-Q., et al. (2012). Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial. Vaccine 30 3295&#x2013;3303. 10.1016/j.vaccine.2012.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.03.010</ArticleId><ArticleId IdType="pubmed">22426327</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z. H., Li C. M., Ling P., Shen F. H., Chen S. H., Liu C. C., et al. (2008). Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J. Infect. Dis. 197 854&#x2013;857. 10.1086/527326</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/527326</ArticleId><ArticleId IdType="pmc">PMC7109938</ArticleId><ArticleId IdType="pubmed">18279075</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao C. C., Liou A. T., Chang Y. S., Wu S. Y., Chang C. S., Lee C. K.et al. (2014). Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71. J. Virol. 88 12485&#x2013;12499. 10.1128/JVI.00692-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00692-14</ArticleId><ArticleId IdType="pmc">PMC4248922</ArticleId><ArticleId IdType="pubmed">25142603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.-Y., Chen T.-C., Weng K.-F., Chang S.-C., Chen L.-L., Shih S.-R. (2009a). Viral and host proteins involved in picornavirus life cycle. J. Biomed. Sci. 16:103. 10.1186/1423-0127-16-103</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-16-103</ArticleId><ArticleId IdType="pmc">PMC2785775</ArticleId><ArticleId IdType="pubmed">19925687</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J. Y., Shih S. R., Pan M., Li C., Lue C. F., Stollar V., et al. (2009b). hnRNP A1 interacts with the 5&#x2032; untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. J. Virol. 83 6106&#x2013;6114. 10.1128/jvi.02476-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02476-08</ArticleId><ArticleId IdType="pmc">PMC2687368</ArticleId><ArticleId IdType="pubmed">19339352</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T.-Y., Chang L.-Y., Hsia S.-H., Huang Y.-C., Chiu C.-H., Hsueh C., et al. (2002a). The 1998 Enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin. Infect. Dis. 34(Suppl. 2) S52&#x2013;S57. 10.1086/338819</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/338819</ArticleId><ArticleId IdType="pubmed">11938497</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T. Y., Chang L. Y., Huang Y. C., Hsu K. H., Chiu C. H., Yang K. D. (2002b). Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr. 91 632&#x2013;635. 10.1111/j.1651-2227.2002.tb03292.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.2002.tb03292.x</ArticleId><ArticleId IdType="pubmed">12162592</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T.-Y., Hsia S.-H., Huang Y.-C., Wu C.-T., Chang L.-Y. (2003a). Proinflammatory cytokine reactions in Enterovirus 71 infections of the central nervous system. Clin. Infect. Dis. 36 269&#x2013;274. 10.1086/345905</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/345905</ArticleId><ArticleId IdType="pubmed">12539066</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T. Y., Twu S. J., Ho M. S., Chang L. Y., Lee C. Y. (2003b). Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg. Infect. Dis. 9 291&#x2013;293. 10.3201/eid0903.020285</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0903.020285</ArticleId><ArticleId IdType="pmc">PMC2963902</ArticleId><ArticleId IdType="pubmed">12643822</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenbaum J. E., Van Dyck P. C., Allen R. G. (1975). Hand, foot and mouth disease associated with coxsackievirus group B. Scand. J. Infect. Dis. 7 161&#x2013;163. 10.3109/inf.1975.7.issue-3.01</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/inf.1975.7.issue-3.01</ArticleId><ArticleId IdType="pubmed">1179172</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou A.-T., Wu S.-Y., Liao C.-C., Chang Y.-S., Chang C.-S., Shih C. (2016). A new animal model containing human SCARB2 and lacking stat-1 is highly susceptible to EV71. Sci. Rep. 6:31151. 10.1038/srep31151</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31151</ArticleId><ArticleId IdType="pmc">PMC4976353</ArticleId><ArticleId IdType="pubmed">27499235</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Dong W., Quan X., Ma C., Qin C., Zhang L. (2012). Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice. Arch. Virol. 157 539&#x2013;543. 10.1007/s00705-011-1198-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-011-1198-2</ArticleId><ArticleId IdType="pubmed">22187102</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M. L., Lee Y. P., Wang Y. F., Lei H. Y., Liu C. C., Wang S. M., et al. (2005). Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 86(Pt 12) 3263&#x2013;3269. 10.1099/vir.0.81195-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81195-0</ArticleId><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhang Z., Zhao X., Yu R., Zhang X., Wu S., et al. (2014). Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression. Viral Immunol. 27 267&#x2013;276. 10.1089/vim.2013.0127</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2013.0127</ArticleId><ArticleId IdType="pubmed">24905060</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.-C., Kuo R.-L., Lin J.-Y., Huang P.-N., Huang Y., Liu H., et al. (2014). Cytoplasmic viral RNA-dependent RNA polymerase disrupts the intracellular splicing machinery by entering the nucleus and interfering with Prp8. PLOS Pathog. 10:e1004199. 10.1371/journal.ppat.1004199</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004199</ArticleId><ArticleId IdType="pmc">PMC4072778</ArticleId><ArticleId IdType="pubmed">24968230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo S. H., Huang Y. C., Huang C. G., Tsao K. C., Li W. C., Hsieh Y. C., et al. (2011). Clinical and epidemiologic features of Coxsackievirus A6 infection in children in northern Taiwan between 2004 and 2009. J. Microbiol. Immunol. Infect. 44 252&#x2013;257. 10.1016/j.jmii.2011.01.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2011.01.031</ArticleId><ArticleId IdType="pubmed">21524960</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Yi L., Zhao J., Yu J., Chen Y., Lin M. C., et al. (2012). Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 86 3767&#x2013;3776. 10.1128/jvi.06687-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.06687-11</ArticleId><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum L. C., Wong K. T., Lam S. K., Chua K. B., Goh A. Y., Lim W. L., et al. (1998). Fatal enterovirus 71 encephalomyelitis. J. Pediatr. 133 795&#x2013;798. 10.1016/S0022-3476(98)70155-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(98)70155-6</ArticleId><ArticleId IdType="pubmed">9842048</ArticleId></ArticleIdList></Reference><Reference><Citation>Machain-Williams C., Dzul-Rosado A. R., Yeh-Gorocica A. B., Rodriguez-Ruz K. G., Noh-Pech H., Talavera-Aguilar L., et al. (2014). Detection of hand, foot and mouth disease in the yucatan peninsula of Mexico. Infect. Dis. Rep. 6:5627. 10.4081/idr.2014.5627</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/idr.2014.5627</ArticleId><ArticleId IdType="pmc">PMC4274403</ArticleId><ArticleId IdType="pubmed">25568757</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P., Stratov I., Dowse G. (1999). Enterovirus 71 outbreak in Western Australia associated with acute flaccid paralysis. Preliminary report. Commun. Dis. Intell. 23:199.</Citation><ArticleIdList><ArticleId IdType="pubmed">10476610</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P., Stratov I., Nagarajan L., Davis S. (2001). Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin. Infect. Dis. 32 236&#x2013;242. 10.1086/318454</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318454</ArticleId><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P. C. (2002). An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26 91&#x2013;107. 10.1016/S0168-6445(02)00070-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-6445(02)00070-0</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng T., Kwang J. (2014). Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice. J. Virol. 88 5803&#x2013;5815. 10.1128/jvi.00289-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00289-14</ArticleId><ArticleId IdType="pmc">PMC4019108</ArticleId><ArticleId IdType="pubmed">24623423</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirand A., Henquell C., Archimbaud C., Ughetto S., Antona D., Bailly J. L., et al. (2012). Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study. Clin. Microbiol. Infect. 18 E110&#x2013;E118. 10.1111/j.1469-0691.2012.03789.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2012.03789.x</ArticleId><ArticleId IdType="pubmed">22404077</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K., Aoki Y., Suto A., Ootani K., Katsushima N., Itagaki T., et al. (2009). Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine 27 3153&#x2013;3158. 10.1016/j.vaccine.2009.03.060</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.03.060</ArticleId><ArticleId IdType="pubmed">19446185</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogensen T. H. (2009). Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 22 240&#x2013;273. 10.1128/CMR.00046-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00046-08</ArticleId><ArticleId IdType="pmc">PMC2668232</ArticleId><ArticleId IdType="pubmed">19366914</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison J. M., Racaniello V. R. (2009). Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells. J. Virol. 83 4412&#x2013;4422. 10.1128/jvi.02177-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02177-08</ArticleId><ArticleId IdType="pmc">PMC2668472</ArticleId><ArticleId IdType="pubmed">19211759</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N., Iwasaki T., Ami Y., Tano Y., Harashima A., Suzaki Y., et al. (2004). Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J. Gen. Virol. 85(Pt 10) 2981&#x2013;2989. 10.1099/vir.0.79883-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.79883-0</ArticleId><ArticleId IdType="pubmed">15448361</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N., Shimizu H., Ami Y., Tano Y., Harashima A., Suzaki Y., et al. (2002). Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J. Med. Virol. 67 207&#x2013;216. 10.1002/jmv.2209</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.2209</ArticleId><ArticleId IdType="pubmed">11992581</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy G., Takatsy S., Kukan E., Mihaly I., Domok I. (1982). Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch. Virol. 71 217&#x2013;227. 10.1007/BF01314873</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01314873</ArticleId><ArticleId IdType="pubmed">6285858</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Shimojima M., Tano Y., Miyamura T., Wakita T., Shimizu H. (2009). Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 15 794&#x2013;797. 10.1038/nm.1961</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Wakita T., Shimizu H. (2010). Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 Infection. PLOS Pathog. 6:e1001174. 10.1371/journal.ppat.1001174</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001174</ArticleId><ArticleId IdType="pmc">PMC2973824</ArticleId><ArticleId IdType="pubmed">21079683</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong K. C., Badmanathan M., Devi S., Leong K. L., Cardosa M. J., Wong K. T. (2008). Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis. J. Neuropathol. Exp. Neurol. 67 532&#x2013;542. 10.1097/NEN.0b013e31817713e7</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31817713e7</ArticleId><ArticleId IdType="pubmed">18520772</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong K. C., Devi S., Cardosa M. J., Wong K. T. (2010). Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J. Virol. 84 661&#x2013;665. 10.1128/jvi.00999-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00999-09</ArticleId><ArticleId IdType="pmc">PMC2798416</ArticleId><ArticleId IdType="pubmed">19864378</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi M. H., Wong S. C., Lewthwaite P., Cardosa M. J., Solomon T. (2010). Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 9 1097&#x2013;1105. 10.1016/S1474-4422(10)70209-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi M. H., Wong S. C., Podin Y., Akin W., del Sel S., Mohan A., et al. (2007). Human enterovirus 71 disease in sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin. Infect. Dis. 44 646&#x2013;656. 10.1086/511073</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/511073</ArticleId><ArticleId IdType="pubmed">17278054</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallansch M. A., Roos R. (2001). &#x201c;Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses,&#x201d; in Fields Virology Vol. 1 eds Knipe D. M., Howley P. M., Griffin D. E. (Hagerstown, MD: Lippincott, Williams &amp; Wilkins; ) 723&#x2013;775.</Citation></Reference><Reference><Citation>Pathinayake P. S., Hsu A. C. Y., Wark P. A. B. (2015). Innate immunity and immune evasion by enterovirus 71. Viruses 7 6613&#x2013;6630. 10.3390/v7122961</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122961</ArticleId><ArticleId IdType="pmc">PMC4690884</ArticleId><ArticleId IdType="pubmed">26694447</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng H., Shi M., Zhang L., Li Y., Sun J., Zhang L., et al. (2014). Activation of JNK1/2 and p38 MAPK signaling pathways promotes enterovirus 71 infection in immature dendritic cells. BMC Microbiol. 14:147. 10.1186/1471-2180-14-147</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-14-147</ArticleId><ArticleId IdType="pmc">PMC4057572</ArticleId><ArticleId IdType="pubmed">24906853</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Ruiz M., Navarro-Mar&#xed; J. M., Palacios del Valle E., Rosa-Fraile M. (2003). Human rhabdomyosarcoma cells for rapid detection of enteroviruses by shell-vial assay. J. Med. Microbiol. 52 789&#x2013;791. 10.1099/jmm.0.05237-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.05237-0</ArticleId><ArticleId IdType="pubmed">12909656</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilipenko E. V., Viktorova E. G., Guest S. T., Agol V. I., Roos R. P. (2001). Cell-specific proteins regulate viral RNA translation and virus-induced disease. EMBO J. 20 6899&#x2013;6908. 10.1093/emboj/20.23.6899</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.23.6899</ArticleId><ArticleId IdType="pmc">PMC125770</ArticleId><ArticleId IdType="pubmed">11726525</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Lim P.-Y., Perera R., Cardosa J., Suksatu A., Kuhn R. J., et al. (2014). Neutralizing antibodies can initiate genome release from human enterovirus 71. Proc. Natl. Acad. Sci. U.S.A. 111 2134&#x2013;2139. 10.1073/pnas.1320624111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1320624111</ArticleId><ArticleId IdType="pmc">PMC3926013</ArticleId><ArticleId IdType="pubmed">24469789</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Cardosa J., Kuhn R. J., Rossmann M. G. (2012). Crystal structure of human enterovirus 71. Science 336 1274&#x2013;1274. 10.1126/science.1218713</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1218713</ArticleId><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Yap M. L., Cardosa J., Kuhn R. J., Rossmann M. G. (2013). Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc. Natl. Acad. Sci. U.S.A. 110 5463&#x2013;5467. 10.1073/pnas.1222379110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222379110</ArticleId><ArticleId IdType="pmc">PMC3619292</ArticleId><ArticleId IdType="pubmed">23509286</ArticleId></ArticleIdList></Reference><Reference><Citation>Pliaka V., Kyriakopoulou Z., Markoulatos P. (2012). Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis. Expert Rev. Vaccines 11 609&#x2013;628. 10.1586/erv.12.28</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/erv.12.28</ArticleId><ArticleId IdType="pubmed">22827246</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabenau H. F., Richter M., Doerr H. W. (2010). Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med. Microbiol. Immunol. 199 45&#x2013;51. 10.1007/s00430-009-0133-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-009-0133-6</ArticleId><ArticleId IdType="pubmed">19941005</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid E., Charleston B. (2014). Type I and III interferon production in response to RNA viruses. J. Interferon Cytokine Res. 34 649&#x2013;658. 10.1089/jir.2014.0066</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2014.0066</ArticleId><ArticleId IdType="pubmed">24956361</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong L., Perelson A. S. (2010). Treatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modeling. Crit. Rev. Immunol. 30 131&#x2013;148. 10.1615/CritRevImmunol.v30.i2.30</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/CritRevImmunol.v30.i2.30</ArticleId><ArticleId IdType="pmc">PMC2882097</ArticleId><ArticleId IdType="pubmed">20370626</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotbart H. A., Webster A. D. (2001). Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin. Infect. Dis. 32 228&#x2013;235. 10.1086/318452</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318452</ArticleId><ArticleId IdType="pubmed">11170912</ArticleId></ArticleIdList></Reference><Reference><Citation>Sazaly A., Sam I. C., Jaliha Y., Meng Keang L., Suzana M., Poh-Sim H. (2009). Enterovirus 71 Outbreak, Brunei. Emerg. Infect. Dis. J. 15 79&#x2013;82. 10.3201/eid1501.080264</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1501.080264</ArticleId><ArticleId IdType="pmc">PMC2660687</ArticleId><ArticleId IdType="pubmed">19116058</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt N. J., Lennette E. H., Ho H. H. (1974). An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129 304&#x2013;309. 10.1093/infdis/129.3.304</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Second J., Velter C., Cal&#xe8;s S., Truchetet F., Lipsker D., Cribier B. (2017). Clinicopathologic analysis of atypical hand, foot, and mouth disease in adult patients. J. Am. Acad. Dermatol. 76 722&#x2013;729. 10.1016/j.jaad.2016.10.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2016.10.022</ArticleId><ArticleId IdType="pubmed">28027826</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah V. A., Chong C. Y., Chan K. P., Ng W., Ling A. E. (2003). Clinical characteristics of an outbreak of hand, foot and mouth disease in Singapore. Ann. Acad. Med. Singapore 32 381&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">12854382</ArticleId></ArticleIdList></Reference><Reference><Citation>Shia K. S., Li W. T., Chang C. M., Hsu M. C., Chern J. H., Leong M. K., et al. (2002). Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors. J. Med. Chem. 45 1644&#x2013;1655. 10.1021/jm010536a</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm010536a</ArticleId><ArticleId IdType="pubmed">11931618</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih S. R., Chen S. J., Hakimelahi G. H., Liu H. J., Tseng C. T., Shia K. S. (2004a). Selective human enterovirus and rhinovirus inhibitors: an overview of capsid-binding and protease-inhibiting molecules. Med. Res. Rev. 24 449&#x2013;474. 10.1002/med.10067</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.10067</ArticleId><ArticleId IdType="pmc">PMC7168432</ArticleId><ArticleId IdType="pubmed">15170592</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih S. R., Stollar V., Li M. L. (2011). Host factors in enterovirus 71 replication. J. Virol. 85 9658&#x2013;9666. 10.1128/jvi.05063-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.05063-11</ArticleId><ArticleId IdType="pmc">PMC3196451</ArticleId><ArticleId IdType="pubmed">21715481</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih S. R., Tsai M. C., Tseng S. N., Won K. F., Shia K. S., Li W. T., et al. (2004b). Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone. Antimicrob. Agents Chemother. 48 3523&#x2013;3529. 10.1128/aac.48.9.3523-3529.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aac.48.9.3523-3529.2004</ArticleId><ArticleId IdType="pmc">PMC514779</ArticleId><ArticleId IdType="pubmed">15328120</ArticleId></ArticleIdList></Reference><Reference><Citation>Shultz L. D., Brehm M. A., Garcia J. V., Greiner D. L. (2012). Humanized mice for immune system investigation: progress, promise and challenges. Nat. Rev. Immunol. 12 786&#x2013;798. 10.1038/nri3311</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3311</ArticleId><ArticleId IdType="pmc">PMC3749872</ArticleId><ArticleId IdType="pubmed">23059428</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M. J., McMinn P., Ooi M. H. (2010). Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 10 778&#x2013;790. 10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton-Hayes S., Weisse M. E., Wilson N. W., Ogershok P. R. (2006). A recurrent presentation of hand, foot, and mouth disease. Clin. Pediatr. 45 373&#x2013;376. 10.1177/000992280604500412</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000992280604500412</ArticleId><ArticleId IdType="pubmed">16703163</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O., Akira S. (2009). Innate immunity to virus infection. Immunol. Rev. 227 75&#x2013;86. 10.1111/j.1600-065X.2008.00737.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2008.00737.x</ArticleId><ArticleId IdType="pmc">PMC5489343</ArticleId><ArticleId IdType="pubmed">19120477</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C. W., Poh C. L., Sam I. C., Chan Y. F. (2013). Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J. Virol. 87 611&#x2013;620. 10.1128/jvi.02226-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan X., Huang X., Zhu S., Chen H., Yu Q., Wang H., et al. (2011). The persistent circulation of enterovirus 71 in People&#x2019;s Republic of China: causing emerging nationwide epidemics since 2008. PLOS ONE 6:e25662. 10.1371/journal.pone.0025662</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025662</ArticleId><ArticleId IdType="pmc">PMC3181342</ArticleId><ArticleId IdType="pubmed">21980521</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang D., Kang R., Coyne C. B., Zeh H. J., Lotze M. T. (2012). PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol. Rev. 249 158&#x2013;175. 10.1111/j.1600-065X.2012.01146.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2012.01146.x</ArticleId><ArticleId IdType="pmc">PMC3662247</ArticleId><ArticleId IdType="pubmed">22889221</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee K. K., Lam T. T., Chan Y. F., Bible J. M., Kamarulzaman A., Tong C. Y., et al. (2010). Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J. Virol. 84 3339&#x2013;3350. 10.1128/jvi.01019-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01019-09</ArticleId><ArticleId IdType="pmc">PMC2838098</ArticleId><ArticleId IdType="pubmed">20089660</ArticleId></ArticleIdList></Reference><Reference><Citation>The IMpact-RSV Study Group (1998). Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102(3 Pt 1) 531&#x2013;537. 10.1542/peds.102.3.531</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.102.3.531</ArticleId><ArticleId IdType="pubmed">9724660</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson S. R., Sarnow P. (2003). Enterovirus 71 contains a type I IRES element that functions when eukaryotic initiation factor eIF4G is cleaved. Virology 315 259&#x2013;266. 10.1016/S0042-6822(03)00544-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0042-6822(03)00544-0</ArticleId><ArticleId IdType="pubmed">14592777</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu P. V., Thao N. T., Perera D., Huu T. K., Tien N. T., Thuong T. C., et al. (2007). Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg. Infect. Dis. 13 1733&#x2013;1741. 10.3201/eid1311.070632</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1311.070632</ArticleId><ArticleId IdType="pmc">PMC3375788</ArticleId><ArticleId IdType="pubmed">18217559</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung W. S., Bakar S. A., Sekawi Z., Rosli R. (2007). DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genet Vaccines Ther. 5:6. 10.1186/1479-0556-5-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-0556-5-6</ArticleId><ArticleId IdType="pmc">PMC3225814</ArticleId><ArticleId IdType="pubmed">17445254</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Xi X., Lei X., Zhang X., Cui S., Wang J., et al. (2013). Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLOS Pathog. 9:e1003231. 10.1371/journal.ppat.1003231</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003231</ArticleId><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Jiang S., Wang Y. (2013). Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice. Biochem. Biophys. Res. Commun. 430 387&#x2013;393. 10.1016/j.bbrc.2012.11.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.11.035</ArticleId><ArticleId IdType="pubmed">23159634</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S. M., Lei H. Y., Huang K. J., Wu J. M., Wang J. R., Yu C. K., et al. (2003). Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J. Infect. Dis. 188 564&#x2013;570. 10.1086/376998</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/376998</ArticleId><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S. M., Liu C. C. (2009). Enterovirus 71: epidemiology, pathogenesis and management. Expert Rev. Anti Infect. Ther. 7 735&#x2013;742. 10.1586/eri.09.45</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eri.09.45</ArticleId><ArticleId IdType="pubmed">19681701</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.-M., Liu C.-C., Tseng H.-W., Wang J.-R., Huang C.-C., Chen Y.-J., et al. (1999). Clinical spectrum of enterovirus 71 infection in children in Southern Taiwan, with an emphasis on neurological complications. Clin. Infect. Dis. 29 184&#x2013;190. 10.1086/520149</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/520149</ArticleId><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Xiao F., Wan P., Pan P., Zhang Y., Liu F., et al. (2017). EV71 3D protein binds with NLRP3 and enhances the assembly of inflammasome complex. PLOS Pathog. 13:e1006123. 10.1371/journal.ppat.1006123</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006123</ArticleId><ArticleId IdType="pmc">PMC5245909</ArticleId><ArticleId IdType="pubmed">28060938</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.-F., Chou C.-T., Lei H.-Y., Liu C.-C., Wang S.-M., Yan J.-J., et al. (2004). A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J. Virol. 78 7916&#x2013;7924. 10.1128/JVI.78.15.7916-7924.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C. N., Lin Y. C., Fann C., Liao N. S., Shih S. R., Ho M. S. (2001). Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20 895&#x2013;904. 10.1016/S0264-410X(01)00385-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(01)00385-1</ArticleId><ArticleId IdType="pubmed">11738755</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Yeo A., Phoon M. C., Tan E. L., Poh C. L., Quak S. H., et al. (2010). The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int. J. Infect. Dis. 14:e1076&#x2013;81. 10.1016/j.ijid.2010.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2010.07.006</ArticleId><ArticleId IdType="pubmed">20952237</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Fujii K., Koike S. (2014). Receptors for enterovirus 71. Emerg. Microbes Infect. 3:e53. 10.1038/emi.2014.49</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2014.49</ArticleId><ArticleId IdType="pmc">PMC4126179</ArticleId><ArticleId IdType="pubmed">26038749</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Koike S. (2011). Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J. Virol. 85 4937&#x2013;4946. 10.1128/JVI.02358-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02358-10</ArticleId><ArticleId IdType="pmc">PMC3126200</ArticleId><ArticleId IdType="pubmed">21389126</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., et al. (2009). Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 15 798&#x2013;801. 10.1038/nm.1992</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J.-J., Su I.-J., Chen P.-F., Liu C.-C., Yu C.-K., Wang J.-R. (2001). Complete genome analysis of enterovirus 71 isolated from an outbreak in Taiwan and rapid identification of enterovirus 71 and coxsackievirus A16 by RT-PCR. J. Med. Virol. 65 331&#x2013;339. 10.1002/jmv.2038</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.2038</ArticleId><ArticleId IdType="pubmed">11536241</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., Chuang H., Yang K. D. (2009). Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol. J. 6:141. 10.1186/1743-422x-6-141</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422x-6-141</ArticleId><ArticleId IdType="pmc">PMC2751754</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S. L., Chou Y. T., Wu C. N., Ho M. S. (2011). Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J. Virol. 85 11809&#x2013;11820. 10.1128/jvi.00297-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00297-11</ArticleId><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye N., Gong X., Pang L. L., Gao W. J., Zhang Y. T., Li X. L., et al. (2015). Cytokine responses and correlations thereof with clinical profiles in children with enterovirus 71 infections. BMC Infect. Dis. 15:225. 10.1186/s12879-015-0965-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-015-0965-1</ArticleId><ArticleId IdType="pmc">PMC4461975</ArticleId><ArticleId IdType="pubmed">26058678</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X., Fan C., Ku Z., Zuo T., Kong L., Zhang C., et al. (2016). Structural basis for recognition of human enterovirus 71 by a bivalent broadly neutralizing monoclonal antibody. PLOS Pathog. 12:e1005454. 10.1371/journal.ppat.1005454</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005454</ArticleId><ArticleId IdType="pmc">PMC4777393</ArticleId><ArticleId IdType="pubmed">26938634</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L., He Y., Chen Y., Kung H. F., He M. L. (2011). Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir. Ther. 16 51&#x2013;58. 10.3851/imp1720</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/imp1720</ArticleId><ArticleId IdType="pubmed">21311108</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C. K., Chen C. C., Chen C. L., Wang J. R., Liu C. C., Yan J. J., et al. (2000). Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J. Biomed. Sci. 7 523&#x2013;528. 10.1007/BF02253368</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02253368</ArticleId><ArticleId IdType="pubmed">11060501</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G., Zhou F., Gu B., Ding C., Feng D., Xie F., et al. (2012). In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. Arch. Virol. 157 669&#x2013;679. 10.1007/s00705-011-1222-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-011-1222-6</ArticleId><ArticleId IdType="pubmed">22245989</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., An D., Liu W., Mao Q., Jin J., Xu L., et al. (2014). Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay. PLOS ONE 9:e100545. 10.1371/journal.pone.0100545</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0100545</ArticleId><ArticleId IdType="pmc">PMC4070950</ArticleId><ArticleId IdType="pubmed">24964084</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Song Z., Qin B., Zhang X., Chen L., Hu Y., et al. (2013). Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model. Antiviral Res. 97 264&#x2013;269. 10.1016/j.antiviral.2012.12.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.029</ArticleId><ArticleId IdType="pubmed">23295352</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Cui W., Liu L., Wang J., Zhao H., Liao Y., et al. (2011). Pathogenesis study of enterovirus 71 infection in rhesus monkeys. Lab. Invest. 91 1337&#x2013;1350. 10.1038/labinvest.2011.82</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2011.82</ArticleId><ArticleId IdType="pubmed">21555996</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F., Xu W., Xia J., Liang Z., Liu Y., Zhang X., et al. (2014). Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N. Engl. J. Med. 370 818&#x2013;828. 10.1056/NEJMoa1304923</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1304923</ArticleId><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F. C., Liang Z.-L., Li X.-L., Ge H.-M., Meng F.-Y., Mao Q.-Y., et al. (2013a). Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial. Lancet 381 1037&#x2013;1045. 10.1016/S0140-6736(12)61764-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61764-4</ArticleId><ArticleId IdType="pubmed">23352749</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F. C., Meng F. Y., Li J. X., Li X. L., Mao Q. Y., Tao H., et al. (2013b). Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 381 2024&#x2013;2032. 10.1016/s0140-6736(13)61049-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(13)61049-1</ArticleId><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang Z.-C., Kou Z.-Q., Bai Y.-J., Cong X., Wang L.-H., Li C., et al. (2015). Epidemiological research on hand, foot, and mouth disease in Mainland China. Viruses 7 6400&#x2013;6411. 10.3390/v7122947</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122947</ArticleId><ArticleId IdType="pmc">PMC4690870</ArticleId><ArticleId IdType="pubmed">26690202</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>